In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
In October 2025, AACR's journals editors highlighted studies on the anticancer function of an Alzheimer’s-related protein, small-molecule-drug conjugates, and...
Frontiers in Cancer Science 2025 cochairs, Soo Chin Lee and Reshma Taneja, preview this international cancer conference in Singapore.
The AACR Conference on the Science of Cancer Health Disparities explored the field's evolving landscape, including funding and and...
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson...
Past recipients of the AACR Global Scholar-in-Training Awards share how their experience with the program has been life-changing.
The psychological toll of cancer can have an impact on patients’ mental health and put them at an increased...
This year, Party with a Purpose honors melanoma researchers Lynn Schuchter and Alexander Huang, and humanitarian honoree Patricia Wellenbach.
Cancer Today's fall issue features articles on the early integration of palliative care for blood cancer patients, accommodating deaf...
A series published in the AACR journal Clinical Cancer Research shared key considerations for improving dosage optimization in oncology.
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...